The company says Daxxify can diminish wrinkles for up to six months, twice as long as Botox.
The FDA’s decision comes years after Revance submitted Daxxify for approval, encountering delays due to the Covid-19 pandemic as well asMore than $14.6 billion. That’s how much the U.S. aesthetics procedures market was worth in 2021,Botox, which is derived from a toxin produced by the bacteria clostridium botulinum, was initially used to create a drug to treat two rare eye muscle disorders.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Approves New Botox RivalThe U.S. Food and Drug Administration approved a new antiwrinkle treatment that could be the most formidable challenger to date to market leader Botox
Source: WSJhealth - 🏆 413. / 53 Read more »
More U.S. adults receiving mental health treatment since start of pandemicMore U.S. adults are receiving mental health treatment. Nearly 22% of all adults received some form of treatment in 2021 — up from about 19% just two years earlier. Go deeper: It ain’t working. That's a good thing. Is this surpringing to anyone? We saw firsthand how little the government and even other people care about disabled individuals, and anyone can become disabled today, tomorrow. Old age finds us all. But when you don't support the community, of course people are going to suffer 🥲
Source: axios - 🏆 302. / 63 Read more »
Chicago influencer shares tale of bad botox treatment; 'I look like Two-Face''I started thinking about it, and realized that people didn't know this was a side effect. I didn't know it was a side effect, and decided that I should share what happened to me,' Whitney Buha said. 3/20
Source: cbschicago - 🏆 546. / 51 Read more »